NEW YORK, May 17 (GenomeWeb News) - AviaraDx, formerly known as Arcturus Bioscience, and Massachusetts General Hospital Cancer Center plan to identify molecular profiles for multiple types of cancer, and hope to develop diagnostics that could help predict the way a patient may respond to certain targeted cancer drugs.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.